Clinical Trial Update: Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating whether adding a DPP-4 inhibitor to existing incretin mimetic therapy improves glycemic outcomes in patients with Type 2 Diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Michael A. Nauck | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2017-01-30